BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32422693)

  • 1. Teledermatology for COVID-19 cutaneous lesions: substitute or supplement?
    Skayem C; Cassius C; Ben Kahla M; Fiani C; Frumholtz L; Mrad M; Petit A; Zuelgaray E; Bagot M; Bouaziz JD; Duong TA
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e532-e533. PubMed ID: 32422693
    [No Abstract]   [Full Text] [Related]  

  • 2. Fighting COVID-19: Early teledermatology lessons learned.
    McGee JS; Reynolds RV; Olbricht SM
    J Am Acad Dermatol; 2020 Oct; 83(4):1224-1225. PubMed ID: 32553677
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of availability, types, and implementation of teledermatology services during COVID-19.
    Gorrepati PL; Smith GP
    J Am Acad Dermatol; 2020 Sep; 83(3):958-959. PubMed ID: 32531304
    [No Abstract]   [Full Text] [Related]  

  • 4. Outpatient Teledermatology Implementation During the COVID-19 Pandemic: Challenges and Lessons Learned.
    Farshchian M; Potts G; Kimyai-Asadi A; Mehregan D; Daveluy S
    J Drugs Dermatol; 2020 Jun; 19(6):683. PubMed ID: 32574014
    [No Abstract]   [Full Text] [Related]  

  • 5. The aftermath of COVID-19 in dermatology practice: What's next?
    Ng JN; Cembrano KAG; Wanitphakdeedecha R; Manuskiatti W
    J Cosmet Dermatol; 2020 Aug; 19(8):1826-1827. PubMed ID: 32502318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Compounding Access Problem for Surgical Care: Innovations in the Post-COVID Era.
    Billig JI; Sears ED
    Ann Surg; 2020 Aug; 272(2):e47-e48. PubMed ID: 32675492
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing the Use Of Teleneurology During the COVID-19 Pandemic.
    Al Kasab S; Almallouhi E; Holmstedt CA
    Telemed J E Health; 2020 Oct; 26(10):1197-1198. PubMed ID: 32329661
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of the COVID-19 Pandemic on Chronic Inflammatory Dermatoses: Mixed Messages Regarding the Dermatologist's Point of View and the Patient's Concerns.
    Fougerousse AC; Maccari F; Reguiai Z; Begon E; Pallure V; Taïeb C; Girard C; Mery-Bossard L
    Acta Derm Venereol; 2020 Aug; 100(15):adv00248. PubMed ID: 32735023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient teledermatology during the COVID-19 pandemic.
    Rismiller K; Cartron AM; Trinidad JCL
    J Dermatolog Treat; 2020 Aug; 31(5):441-443. PubMed ID: 32364809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The digital divide: How COVID-19's telemedicine expansion could exacerbate disparities.
    Bakhtiar M; Elbuluk N; Lipoff JB
    J Am Acad Dermatol; 2020 Nov; 83(5):e345-e346. PubMed ID: 32682890
    [No Abstract]   [Full Text] [Related]  

  • 11. Noncutaneous considerations of COVID-19 for dermatology practices.
    Ali FR; Al-Niaimi F
    J Cosmet Dermatol; 2020 Jul; 19(7):1544. PubMed ID: 32298514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectively engaging geriatric patients via teledermatology.
    Simpson CL; Kovarik CL
    J Am Acad Dermatol; 2020 Dec; 83(6):e417-e418. PubMed ID: 32497703
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing teledermatology visits for dermatology resident education during the COVID-19 pandemic.
    Oldenburg R; Marsch A
    J Am Acad Dermatol; 2020 Jun; 82(6):e229. PubMed ID: 32283238
    [No Abstract]   [Full Text] [Related]  

  • 14. Colorectal emergency surgery in a COVID-19 referral hospital during the phase 2 in Italy.
    Lisi G; Campanelli M; Villa M; Grande S; Grande M
    Int J Colorectal Dis; 2020 Nov; 35(11):2137-2138. PubMed ID: 32607618
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 Supply Chain Considerations for Prescription Drugs in Dermatology.
    Egger A; Abrouk M; Brodsky M; Kirsner RS
    J Drugs Dermatol; 2020 Jun; 19(6):666-667. PubMed ID: 32574019
    [No Abstract]   [Full Text] [Related]  

  • 16. Teledermatology for acne patients: How to reduce face-to-face visits during COVID-19 pandemic.
    Villani A; Annunziata MC; Abategiovanni L; Fabbrocini G
    J Cosmet Dermatol; 2020 Aug; 19(8):1828. PubMed ID: 32490578
    [No Abstract]   [Full Text] [Related]  

  • 17. Remote management of hidradenitis suppurativa in a pandemic era of COVID-19.
    Kang NC; Hsiao J; Shi V; Naik HB; Lowes MA; Alavi A
    Int J Dermatol; 2020 Sep; 59(9):e318-e320. PubMed ID: 32578210
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging Stronger from the COVID-19 Crisis: Recover, Reposition, and Redesign.
    Waldeck A; Srivastava P; Picken HA
    Popul Health Manag; 2020 Oct; 23(5):339-343. PubMed ID: 32882161
    [No Abstract]   [Full Text] [Related]  

  • 19. Low risk of COVID-19 transmission in GI endoscopy.
    Repici A; Aragona G; Cengia G; Cantù P; Spadaccini M; Maselli R; Carrara S; Anderloni A; Fugazza A; Pace F; Rösch T;
    Gut; 2020 Nov; 69(11):1925-1927. PubMed ID: 32321857
    [No Abstract]   [Full Text] [Related]  

  • 20. Guiding principles for prioritization of limited in-person dermatology appointments during the COVID-19 pandemic.
    Stoff BK; Blalock TW; Swerlick RA; MacKelfresh JB; Lawley LP; Chen SC
    J Am Acad Dermatol; 2020 Oct; 83(4):1228-1230. PubMed ID: 32682028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.